Cidara Therapeutics Inc - ESG Rating & Company Profile powered by AI
This SDG score for Cidara Therapeutics Inc represents the company's transparency towards the UN Sustainable Development Goals. Other companies in the scoring industry group for Cidara Therapeutics Inc are displayed. This webpage is a zero-cost Environmental, Social and Governance analysis covering Cidara Therapeutics Inc.
Cidara Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.5; made up of an environmental score of 4.0, social score of 8.0 and governance score of 6.9.
6.5
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 483 | Provention Bio Inc | 6.6 | High |
| 483 | PuraPharm Corp Ltd | 6.6 | High |
| 511 | Cidara Therapeutics Inc | 6.5 | High |
| 511 | BPH Energy Ltd | 6.5 | High |
| 511 | Abcam PLC | 6.5 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Cidara Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Cidara Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Cidara Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Cidara Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Cidara Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Cidara Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Cidara Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Cidara Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Cidara Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Cidara Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Cidara Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Cidara Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Cidara Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Cidara Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Cidara Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Cidara Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Cidara Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Cidara Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Cidara Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Cidara Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Cidara Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Cidara Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Cidara Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Cidara Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Cidara Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Cidara Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Cidara Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Cidara Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Cidara Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Cidara Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Cidara Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Cidara Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Cidara Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Cidara Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Cidara Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Cidara Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Cidara Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.